Skip to main content
Premium Trial:

Request an Annual Quote

Partners Will Use Zyomyx System for Clinical Protein Analysis

NEW YORK, June 24-Boston's Partners health care system has struck a broad alliance with Zyomyx to use the company's protein chip system in clinical research.


Under a three-year agreement, Zyomyx and Partners together will establish a protein profiling research facility to identify and validate biomarkers associated with disease. No financial details were disclosed.


Zyomyx will provide a protein analysis system, which includes workstation, software and ready-to-use antibody chips.


Partners is a consortium of medical facilities that includes Harvard Medical School and its affiliated teaching hospitals, Massachusetts General Hospital and Boston's Brigham and Women's Hospital.


The agreement establishes Zyomyx's first major academic protein analysis research center.


For more information, see the company website.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.